No Yes If YES, please describe. If you wish to add additional information for the IRB to consider, please add it here: ANCILLARY REVIEWS: Please review the following sections to confirm or determine if any ancillary reviews are required. For any ancillary reviewer than IBC, please share the IRBNet submission with the ancillary reviewer. Although the IRB may grant a approval” of the research when ancillary review is required, the research CANNOT begin until the IRB has granted final IRB “conditional approval after all required ancillary reviews are complete. UHB Pathology Laboratories: NOTE: The criteria for the requirement of pathology ancillary review and approval were clarified on February 16, 2018. Check the box below to indicate whether the research involves any of the following: At least one box MUST be checked. (12a1) Patient Material: Use of any past, present, or future UHB patient material (tissue, blood and fluids) requires UHB Pathology Review, except for the following: 1) Extra blood sample or extra urine sample which will not be tested in UHB pathology laboratory. 2) Tissue listed in UHB Exempt Tissue Policy: “.” (12a2) Services or assistance of the UHB Pathology Laboratories (Clinical Laboratory, Histology Lab and/or Surgical Pathology). (12a3) None of the above. UHB Pathology Laboratories ancillary review is not required. . If uncertain about the need for ancillary review by UHB Pathology, please consult or It is best to set up an appointment. A list of all specimens that you propose using for your research will be needed. If they state that Pathology Ancillary review is not required, they will document this in an email. A copy of the e-mail must be attached to the IRB submission. If box or is checked above, please indicate which past IRBNet package contains UHB Pathology Approval: “12a1” “12a2”
No Yes If YES, please describe. If you wish to add additional information for the IRB to consider, please add it here: ANCILLARY REVIEWS: Please review the following sections to confirm or determine if any ancillary reviews are required. For any ancillary reviewer than IBC, please share the IRBNet submission with the ancillary reviewer. Although the IRB may grant a “conditional approval” of the research when ancillary review is required, the research CANNOT begin until the IRB has granted final IRB approval after all required ancillary reviews are complete. UHB Pathology Laboratories: NOTE: The criteria for the requirement of pathology ancillary review and approval were clarified on February 16, 2018. Check the box below to indicate whether the research involves any of the following: At least one box MUST be checked. (12a1) Patient Material: Use of any past, present, or future UHB patient material (tissue, blood and fluids) requires UHB Pathology Review, except for the following: 1) Extra blood sample or extra urine sample which will not be tested in UHB pathology laboratory. 2) Tissue listed in UHB Exempt Tissue Policy: “.” (12a2) Services or assistance of the UHB Pathology Laboratories (Clinical Laboratory, Histology Lab and/or Surgical Pathology). (12a3) None of the above. UHB Pathology Laboratories ancillary review is not required. If uncertain about the need for ancillary review by UHB Pathology, please consult or . It is best to set up an appointment. A list of all specimens that you propose using for your research will be needed. If they state that Pathology Ancillary review is not required, they will document this in an email. A copy of the e-mail must be attached to the IRB submission. If box “12a1” or “12a2” is checked above, please indicate which past IRBNet package contains UHB Pathology Approval: